PUR-WASH- water solution 
Niagara Pharmaceuticals Inc.

----------

Pur-Wash

Drug Facts

Active ingredient

Purified water 98.3%

Purpose

Eyewash

Use

For cleansing the eye to help relieve irritation or burning by removing loose foreign material

Warnings

For external use only

Do not use

  • if you experience any open wounds in or near the eyes and obtain immediate medical treatment
  • if solution changes color or becomes cloudy

When using this product

  • to avoid contamination, do not touch tip of container to any surface
  • do not reuse
  • once opened, discard

Stop use and ask a doctor if you have any of the following

  • continued redness or irritation of the eye
  • condition worsens or persists
  • eye pain
  • changes in vision

Keep out of reach of children.

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

Other information

Inactive ingredients

boric acid, sodium borate, sodium chloride

Questions ?

☎ Call 905 690-6277 9 a.m. to 5 p.m. EST Mon-Fri

Manufactured by:
Niagara Pharmaceuticals Inc.
60 Innovation Dr.
Flamborough ON L9H 7P3

PRINCIPAL DISPLAY PANEL - 946 mL Bottle Label

Pur-Wash

Purified Water, 98.3%
Ophthalmic Solution
Eyewash

Single Use

Manufactured by:
Niagara Pharmaceuticals Inc.
60 Innovation Dr.
Flamborough ON L9H 7P3
Made in Canada

Sterile Solution

32 Fl Oz [946 mL]

PRINCIPAL DISPLAY PANEL - 946 mL Bottle Label
PUR-WASH 
water solution
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:65785-164
Route of AdministrationOPHTHALMIC
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
WATER (UNII: 059QF0KO0R) (WATER - UNII:059QF0KO0R) WATER929 g  in 946 mL
Inactive Ingredients
Ingredient NameStrength
BORIC ACID (UNII: R57ZHV85D4)  
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
SODIUM BORATE (UNII: 91MBZ8H3QO)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:65785-164-01473 mL in 1 BOTTLE, UNIT-DOSE; Type 0: Not a Combination Product09/12/2011
2NDC:65785-164-02946 mL in 1 BOTTLE, UNIT-DOSE; Type 0: Not a Combination Product09/12/2011
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
NDANDA02230509/12/2011
Labeler - Niagara Pharmaceuticals Inc. (205477792)
Establishment
NameAddressID/FEIBusiness Operations
Niagara Pharmaceuticals Inc.205477792manufacture(65785-164)

Revised: 10/2018
Document Id: 777cde52-c3f4-4140-e053-2991aa0ac858
Set id: c3225d26-a520-4bfb-bf9c-80340f1b830e
Version: 2
Effective Time: 20181005
 
Niagara Pharmaceuticals Inc.